Latest total liabilities for FBLG: $3.3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
FibroBiologics (FBLG) currently reports a total liabilities of $3.3M as of June 2026. That compares with $13M in the prior-year period — down 74.8% year over year. Use the charts on this page to explore FibroBiologics's total liabilities history and peer comparisons.
FibroBiologics's total liabilities decreased from $13M to $3.3M — a 74.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
FibroBiologics reported $3.3M in total liabilities as of June 2026. That compares with $13M in the prior-year period — down 74.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $3.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for FibroBiologics, and consider following FBLG for alerts when major investors trade the stock.